Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide

Published:2015-01-13 Issue:4 Volume:64 Page:447-457
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Morin-Brureau Mélanie,Hooper Kirsten M.,Prosniak Michael,Sauma Sami,Harshyne Larry A.,Andrews David W.,Hooper D. Craig

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1654-z.pdf

Reference43 articles.

1. Smith JS, Jenkins RB (2000) Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5:D213–D231

2. Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1:97–117

3. Avgeropoulos NG, Batchelor TT (1999) New treatment strategies for malignant gliomas. Oncologist 4:209–224

4. Jackson C, Ruzevick J, Phallen J, Belcaid Z, Lim M (2011) Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. Clin Dev Immunol 2011:732413

5. Madan RA, Gulley JL (2011) Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer. Immunotherapy 3:27–31

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target;Frontiers in Immunology;2024-02-14

2. Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients;Future Oncology;2023-12-07

3. Drugging IGF-1R in cancer: New insights and emerging opportunities;Genes & Diseases;2023-01

4. RNA Therapeutics for Cancers;RNA Therapeutics - History, Design, Manufacturing, and Applications [Working Title];2022-09-16

5. Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma;Journal of Clinical Medicine;2022-02-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3